Jade Biosciences, Inc.
Pharmaceutical Preparations · Waltham, MA, United States
- PrincipalsBradford D. DahmsChief Financial OfficerTom FrohlichChief Executive Officerand 4 more
- CompanyJade Biosciences, Inc.Waltham, MA, United States
- Phone line+1 (781) 312-3013General business
Jade Biosciences, Inc. is an SEC-registered Nasdaq-listed company (ticker JBIO) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chief executive
Tom FrohlichChief Executive Officer
Finance
Bradford D. DahmsChief Financial Officer
Everyone else on file (2)
Andrew James KingOfficer (see SEC filing)
Elizabeth BaltaOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Bradford D. Dahms — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Tom Frohlich — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Andrew James King — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Elizabeth Balta — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Jazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capabilityZai Lab LtdPharmaceutical Preparations · Shanghai1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityKazia Therapeutics LtdPharmaceutical Preparations · Sydney Nsw1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capability